Search
Search Results
##search.searchResults.foundPlural##
-
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1789PDF: 798HTML: 10223Figures 1,2,3: 171 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1046PDF: 1058HTML: 432 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1946PDF: 808HTML: 216 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2445PDF: 917HTML: 513 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13239PDF: 956HTML: 7280 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1032PDF: 959HTML: 319 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
627PDF: 472HTML: 82 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2146PDF: 1461HTML: 260 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1244PDF: 717HTML: 312 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3111PDF: 1107HTML: 1745 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3477PDF: 869HTML: 1644figure 1: 160Untitled: 185 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1730PDF: 526HTML: 16963Figure 4: 163Figure 3: 137Figure 2: 142Figure 1: 172 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4336PDF: 901HTML: 1313Table1: 177 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3840PDF: 749HTML: 1840 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
812PDF: 536HTML: 4010 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3147PDF: 1574HTML: 254 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1074PDF: 484HTML: 8152 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4070PDF: 1574HTML: 923 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2732PDF: 1114HTML: 3273 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1154PDF: 784HTML: 1763 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1094PDF: 756HTML: 201 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1397PDF: 926HTML: 316 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
938PDF: 1202HTML: 101 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1812PDF: 826HTML: 1570 -
-
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
923PDF: 567HTML: 2183Cover Letter: 189 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4428PDF: 1912HTML: 17725







